Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Titan Pharmaceuticals Inc

Titan Pharmaceuticals Inc (TTNP)

Closed July 14 4:00PM
After Hours: 7:47PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 149k95k121k98k83k3k00
Operating Income -2.44M-2.64M-2.61M-1.7M-1.59M-2.06M-1.93M-1.06M
Pre Tax Income -2.46M-2.64M-2.57M-1.68M-1.59M-338k-1.97M-1.06M
Net Income -2.46M-2.64M-2.57M-1.68M-1.59M-338k-1.97M-1.06M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -2.47M-2.66M-2.59M-1.7M-1.59M-327k-1.96M-1.06M
EBITDA -2.39M-2.6M-2.57M-1.65M-1.55M-2.03M-1.93M-1.06M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 15.07M215k6.62M3.61M4.84M1.53M557k184k
Operating Income 4.34M-14.5M-8.26M-16.84M-7.35M-9.35M-10.24M-7.28M
Pre Tax Income 5.14M-14.31M-9.02M-16.46M-7.41M-8.78M-10.21M-5.57M
Net Income 5.14M-14.31M-9.31M-16.46M-18.24M-8.78M-10.21M-5.57M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0.235-0.656-0.684-0.284-2.355-0.834-0.653-0.336
EBIT 4.27M-14.56M-8.27M-16.6M-5.72M-8.78M-10.26M-5.57M
EBITDA 4.72M-14.09M-7.88M-16.6M-7.06M-9.13M-10.04M-7.17M

Your Recent History

Delayed Upgrade Clock